Development Level

Tbio 21 | 10,625
Tchem 14 | 1,890
Tclin 7 | 602

IMPC Term

embryonic lethality prior to t... 2 | 187
increased circulating HDL chol... 2 | 63
preweaning lethality, complete... 2 | 633
abnormal behavior 1 | 226
abnormal gait 1 | 51
abnormal lens morphology 1 | 73
abnormal sensory capabilities/... 1 | 3
abnormal tooth morphology 1 | 24
absent vibrissae 1 | 14
cataract 1 | 26
decreased circulating creatini... 1 | 31
decreased circulating glucose ... 1 | 121
decreased circulating serum al... 1 | 79
decreased circulating sodium l... 1 | 18
decreased leukocyte cell numbe... 1 | 54
decreased prepulse inhibition 1 | 52
enlarged lymph nodes 1 | 27
immune system phenotype 1 | 17
increased B cell number 1 | 23
increased circulating LDL chol... 1 | 15
increased circulating alkaline... 1 | 119
increased circulating bilirubi... 1 | 16
increased circulating choleste... 1 | 53
increased circulating free fat... 1 | 17
increased circulating sodium l... 1 | 71
increased circulating triglyce... 1 | 24
increased hemoglobin content 1 | 45
increased mature B cell number 1 | 12
increased mean corpuscular hem... 1 | 25
increased or absent threshold ... 1 | 128
male infertility 1 | 62
oligodactyly 1 | 14
small adrenal glands 1 | 15

Disease

osteosarcoma 28 | 7,933
glioblastoma 26 | 5,572
ovarian cancer 26 | 8,484
Cancer 25 | 2,346
medulloblastoma, large-cell 24 | 6,234
atypical teratoid / rhabdoid tumor 21 | 4,369
lung cancer 21 | 4,466
psoriasis 21 | 6,685
diabetes mellitus 20 | 1,663
Breast cancer 17 | 3,094
non-small cell lung cancer 17 | 2,798
pancreatic cancer 17 | 2,300
malignant mesothelioma 16 | 3,162
intraductal papillary-mucinous adenoma (IPMA) 15 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 15 | 3,289
invasive ductal carcinoma 15 | 2,950
pediatric high grade glioma 14 | 2,712
pilocytic astrocytoma 14 | 3,086
intraductal papillary-mucinous carcinoma (IPMC) 13 | 2,988
lung adenocarcinoma 13 | 2,713
lung carcinoma 13 | 2,844
primitive neuroectodermal tumor 13 | 3,031
oligodendroglioma 12 | 2,849
ulcerative colitis 12 | 2,087
Kidney disease 11 | 396
Obesity 11 | 616
interstitial cystitis 11 | 2,299
Carcinoma 10 | 2,147
Lung disease 10 | 132
Mammary Neoplasms 10 | 410
Rheumatoid Arthritis 10 | 1,160
Stomach Neoplasms 10 | 282
adrenocortical carcinoma 10 | 1,427
breast carcinoma 10 | 1,614
ductal carcinoma in situ 10 | 1,745
Adenoma 9 | 165
Alzheimer's disease 9 | 644
Cerebrovascular disease 9 | 231
Heart disease 9 | 279
Lung Neoplasms 9 | 171
Multiple myeloma 9 | 1,327
Prostatic Neoplasms 9 | 471
acute quadriplegic myopathy 9 | 1,157
adult high grade glioma 9 | 2,148
astrocytic glioma 9 | 2,241
astrocytoma 9 | 1,493
cutaneous lupus erythematosus 9 | 1,056
pancreatic carcinoma 9 | 567
pancreatic ductal adenocarcinoma liver metastasis 9 | 1,795
subependymal giant cell astrocytoma 9 | 2,287
Arthritis 8 | 248
Atherosclerosis 8 | 275
Colonic Neoplasms 8 | 126
Liver carcinoma 8 | 217
Melanoma 8 | 261
Neurodegenerative disease 8 | 383
Toxic encephalopathy 8 | 131
colon cancer 8 | 1,475
pituitary cancer 8 | 1,972
posterior fossa group A ependymoma 8 | 1,511
Adenocarcinoma 7 | 115
Coronary artery disease 7 | 240
Hyperglycemia 7 | 120
Hypertension 7 | 287
Liver disease 7 | 219
Metabolic syndrome X 7 | 155
Schizophrenia 7 | 501
Waldenstrons macroglobulinemia 7 | 765
medulloblastoma 7 | 1,524
nasopharyngeal carcinoma 7 | 1,056
non-small cell lung carcinoma 7 | 413
Amyotrophic Lateral Sclerosis 6 | 431
Brain disease 6 | 83
Peripheral Neuropathy 6 | 303
Polycystic Ovary Syndrome 6 | 332
Vascular disease 6 | 281
chronic rhinosinusitis 6 | 512
cystic fibrosis 6 | 1,665
ependymoma 6 | 2,514
gastric cancer 6 | 430
group 4 medulloblastoma 6 | 1,875
hepatocellular carcinoma 6 | 532
nephrosclerosis 6 | 329
posterior fossa group B ependymoma 6 | 1,530
sonic hedgehog group medulloblastoma 6 | 1,482
tuberculosis 6 | 1,557
Bladder Neoplasm 5 | 109
Disease Progression 5 | 125
Endometriosis 5 | 535
Hypertensive disease 5 | 193
Inflammatory bowel disease 5 | 142
Multiple Sclerosis 5 | 498
Neuroblastoma 5 | 78
Parkinson's disease 5 | 364
Pick disease 5 | 1,893
Seizures 5 | 95
dermatomyositis 5 | 933
fibroadenoma 5 | 557
gastric carcinoma 5 | 832
juvenile dermatomyositis 5 | 1,189

Tissue

Digestive Tract 42 | 18,473
Female tissues 42 | 18,647
Liver and Pancreas 42 | 18,136
Blood and immune system 41 | 17,995
Cardiovascular System 41 | 17,958
Endocrine System 41 | 18,512
Male tissues 41 | 17,969
Nervous System 41 | 18,561
Urinary Tract 41 | 18,444
Skin and soft tissues 40 | 18,115
Respiratory system 38 | 17,484

Target Family

Non-IDG 16 | 11,971
Enzyme 14 | 4,146
Kinase 5 | 634
Transcription Factor 3 | 1,400
Transporter 2 | 473
GPCR 1 | 406
Nuclear Receptor 1 | 48

Grant Application

5P41RR000954-34 42 | 42
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-1 beta IL1B Tclin Non-IDG -4.34333 22444.2 1345
Apolipoprotein E APOE Tbio Non-IDG -4.17470 15380.4 788
E3 ubiquitin-protein ligase Mdm2 MDM2 Tchem Enzyme -3.38438 2174.7 1062
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Lysozyme C LYZ Tbio Enzyme -3.63761 4321.0 420
Catenin alpha-1 CTNNA1 Tbio Non-IDG -1.91334 73.6 399
Tyrosine-protein phosphatase non-receptor type 11 PTPN11 Tchem Enzyme -3.06784 1308.8 971
Arylsulfatase H ARSH Tbio Enzyme -2.12798 119.1 77
Growth hormone variant GH2 Tbio Non-IDG -3.33598 1735.5 139
Peroxisome proliferator-activated receptor gamma PPARG Tclin Nuclear Receptor -3.91275 8950.6 711